DRYeye Forte

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

d-alpha-tocopherol, Quantity: 26.83 mg; colecalciferol, Quantity: 5 microgram; concentrated fish Omega-3 triglycerides, Quantity: 800 mg (Equivalent: docosahexaenoic acid, Qty 192 mg; Equivalent: eicosapentaenoic acid, Qty 288 mg); Borago officinalis, Quantity: 454.55 mg (Equivalent: gamma-linolenic acid, Qty 100 mg); mixed (low-alpha type) tocopherols concentrate, Quantity: 7.301 mg

Disponible depuis:

MD Eyecare Pty Ltd

DCI (Dénomination commune internationale):

Borago officinalis,colecalciferol,concentrated fish Omega-3 triglycerides,d-alpha-Tocopherol,mixed (low-alpha type) tocopherols

forme pharmaceutique:

Capsule, soft

Composition:

Excipient Ingredients: vegetable oil; d-alpha-tocopherol; purified water; Gelatin; Soya Oil; glycerol; Orange Oil

Mode d'administration:

Oral

indications thérapeutiques:

Antioxidant/Reduce free radicals formed in the body ; Relieve dry eyes ; Maintain/support eye health ; Relieve itchy eyes ; Relieve eye redness ; Maintain/support general health and wellbeing ; Anti-inflammatory/relieve inflammation ; Maintain/support bone health ; Aids/assists healthy bone development/growth/building ; Vitamin D helps calcium absorption (or words of like intent) and a diet deficient in calcium can lead to osteoporosis in later life ; Decrease/reduce/relieve mild joint inflammation/swelling ; Maintain/support cardiovascular system health ; Maintain/support heart health ; Maintain/support immune system health ; Maintain/support muscle strength ; Aids/assists the body to cope with environmental stress ; Maintain/support cognitive function/mental function ; Maintain/support memory/mental recall ; Maintain/support brain function ; Maintain/support nervous system function ; Decrease/reduce/relieve symptoms of menopause

Descriptif du produit:

Visual Identification: ;

Statut de autorisation:

Licence status A

Date de l'autorisation:

2016-10-31